18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall

C. Yi; X. Wang; X. Shi; X. Zhang; Z. Chen

doi:10.3413/PDF-5236-19157

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 2012; 51(06): N53-N54
DOI: 10.3413/PDF-5236-19157

Case report

Schattauer GmbH

¹⁸F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall

C. Yi

¹Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

,

X. Wang

¹Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

,

X. Shi

¹Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

,

X. Zhang

¹Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

,

Z. Chen

¹Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

› Author Affiliations

Abstract

Full Text

References

References
1 Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A 1977; 85A: 127-140.
2 Enomoto K, Inohara H, Hamada K. et al. FDG PET imaging of myxofibrosarcoma on the sphenoid sinus. Clin Nucl Med 2008; 33: 421-422.
3 Graadt van Roggen JF, Hogendoorn PC, Fletcher CDM. Myxoid tumours of soft tissue. Histopathology 1999; 35: 291-312.
4 Hambleton C, Noureldine S, Gill F. et al. Myxofibrosarcoma with metastasis to the lungs, pleura, and mediastinum: a case report and review of literature. Int J Clin Exp Med 2012; 5: 92-95.
5 Ito K, Masuda-Miyata Y, Wada S. et al. ¹⁸F-FDG PET/CT imaging of bulky myxofibrosarcoma in chest wall. Clin Nucl Med 2011; 36: 212-213.
6 Kaya M, Wada T, Nagoya S. et al. MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skeletal Radiol 2008; 37: 1085-1090.
7 Mansoor A, White Jr. CR. Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms. Am J Dermatopathol 2003; 25: 281-286.
8 Mentzel T, Calonje E, Wadden C. et al. Myxofibro - sarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996; 20: 391-405.
9 Mutter RW, Singer S, Zhang Z. et al. The enigma of myxofibrosarcoma of the extremity. Cancer 2012; 118: 518-527.
10 Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol 2008; 97: 330-339.
11 Tewfik JN, Greene GS. Fluorine-18-deoxyglucosepositron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay. Curr Probl Diagn Radiol 2008; 37: 178-188.
12 Waters B, Panicek DM, Lefkowitz RA. et al. Lowgrade myxofibrosarcoma: CT and MRI patterns in recurrent disease. AJR Am J Roentgenol 2007; 188: W193-W198.
13 Weckesser E, Redeker J, Kühnel G. et al. Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography. Nuklearmedizin 2000; 39: N38-N39.